Recent analyst coverage updates for Rocket Lab USA have painted a uniformly optimistic picture for the aerospace company’s equity. The consensus view points to significant upside potential, with the average price target standing at $89.36. This represents an approximate 33% increase from the previous closing price of $68.00. A notable divergence has emerged between the current market valuation and analyst expectations, particularly as the share price remains nearly 32% below its January peak.
Financial Projections and Ratings Consensus
The current analyst consensus is categorized as “Moderate Buy.” This stance is supported by nine “Buy” recommendations compared to four advising investors to “Hold.” Clear Street analyst Gregory Pendy initiated coverage with an $88.00 price target and a “Buy” rating. His bullish thesis is anchored on an anticipated annual revenue growth rate of 35% through 2030. In a separate move, Cantor Fitzgerald reaffirmed its “Buy” opinion, setting a target of $85.00.
Looking ahead to fiscal year 2026, market experts project revenue growth of 42%. The forward price-to-earnings ratio is calculated at 45.1x, a multiple that reflects high growth expectations but leaves minimal room for operational setbacks.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
Operational Backlog and the Neutron Catalyst
Rocket Lab’s financial foundation is bolstered by a firm contract backlog exceeding $2 billion. A significant component is a $190 million agreement with the U.S. Department of Defense for 20 HASTE launches utilizing its Electron rocket.
However, the company’s primary growth narrative centers on the development of its Neutron rocket. This 43-meter, partially reusable launch vehicle is designed to target the medium-lift payload segment. Recent reports indicate key components are now ready for assembly, though the inaugural launch timeline has been adjusted to late 2026 or early 2027. Rocket Lab intends to price Neutron missions between $50 million and $55 million, strategically positioning it below the cost of a SpaceX Falcon 9 launch for comparable payloads.
To fund the Neutron program, the company is utilizing a $1 billion equity program. The potential for share dilution associated with this financing remains a consideration for investors. Demonstrating steady execution in its core business, Rocket Lab recently completed its 84th Electron launch, underscoring its operational reliability in the small-launch sector.
Ad
Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from March 25 delivers the answer:
The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.
Rocket Lab USA: Buy or sell? Read more here...









